Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunoglobulin M"" wg kryterium: Temat


Tytuł :
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
Autorzy :
Yang Y; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Wang X; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Du RH; Wuhan pulmonary hospital, Wuhan, People's Republic of China.
Zhang W; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Si HR; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Zhu Y; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Shen XR; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Li Q; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Li B; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Men D; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Zhou YN; Hubei provincial hospital of TCM, Wuhan, People's Republic of China.
Wang H; Wuhan Municipal Health Commission, Wuchang branch, Wuhan, People's Republic of China.
Tong XL; Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
Zhang XE; National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, People's Republic of China.
Shi ZL; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.
Zhou P; CAS Key Laboratory of Special Pathogens & State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.; Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology & Wuhan Jinyintan Hospital, Wuhan, People's Republic of China.
Pokaż więcej
Źródło :
Emerging microbes & infections [Emerg Microbes Infect] 2021 Dec; Vol. 10 (1), pp. 905-912.
Typ publikacji :
Journal Article
MeSH Terms :
Asymptomatic Infections*
COVID-19 Serological Testing*
Pandemics*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*immunology
Immunoglobulin G/*blood
Immunoglobulin M/*blood
SARS-CoV-2/*immunology
Antibodies, Neutralizing/biosynthesis ; Antibodies, Viral/biosynthesis ; B-Lymphocytes ; COVID-19/epidemiology ; COVID-19 Nucleic Acid Testing ; China/epidemiology ; Convalescence ; Cytokines/blood ; Disease Susceptibility ; Enzyme-Linked Immunosorbent Assay ; Follow-Up Studies ; Food Handling ; Genome, Viral ; Humans ; Immunity, Herd ; Immunoglobulin G/biosynthesis ; Immunoglobulin M/biosynthesis ; Lymphocyte Count ; Lymphopenia/etiology ; Phylogeny ; RNA, Viral/blood ; Real-Time Polymerase Chain Reaction ; SARS-CoV-2/genetics ; Seroepidemiologic Studies ; Sputum/virology
Czasopismo naukowe
Tytuł :
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Autorzy :
Zhu L; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Xu X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
Zhu B; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Guo X; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Xu K; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Song C; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Fu J; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Yu H; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Kong X; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Peng J; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Huang H; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Zou X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Ding Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
Bao C; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Zhu F; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.; Key Laboratory of Infectious Diseases, School of Public Health, Nanjing Medical University, Nanjing, China.
Hu Z; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Wu M; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Shen H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło :
Microbiology spectrum [Microbiol Spectr] 2021 Oct 31; Vol. 9 (2), pp. e0059021. Date of Electronic Publication: 2021 Sep 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
SARS-CoV-2/*immunology
Adolescent ; Adult ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; COVID-19/immunology ; Child ; Female ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Immunologic Memory/immunology ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
Autorzy :
Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Hinton PR; IGM Biosciences, Mountain View, CA, USA.
Liu X; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Muruato AE; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Ng DC; IGM Biosciences, Mountain View, CA, USA.
Biswas S; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Liu Y; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Pandya D; IGM Biosciences, Mountain View, CA, USA.
Menachery VD; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Rahman S; IGM Biosciences, Mountain View, CA, USA.
Cao YA; IGM Biosciences, Mountain View, CA, USA.
Deng H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Carlin KB; IGM Biosciences, Mountain View, CA, USA.
Liu J; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Su H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Haanes EJ; IGM Biosciences, Mountain View, CA, USA.
Keyt BA; IGM Biosciences, Mountain View, CA, USA. .
Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. .
Carroll SF; IGM Biosciences, Mountain View, CA, USA. .
Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. .; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA. .; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. .; Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. .; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA. .
An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. .
Pokaż więcej
Źródło :
Nature [Nature] 2021 Jul; Vol. 595 (7869), pp. 718-723. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*prevention & control
COVID-19/*virology
Immunoglobulin M/*administration & dosage
Immunoglobulin M/*immunology
SARS-CoV-2/*classification
SARS-CoV-2/*immunology
Administration, Intranasal ; Angiotensin-Converting Enzyme 2/antagonists & inhibitors ; Angiotensin-Converting Enzyme 2/metabolism ; Animals ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Neutralizing/administration & dosage ; Antibodies, Neutralizing/adverse effects ; Antibodies, Neutralizing/genetics ; Antibodies, Neutralizing/immunology ; Apoptosis Regulatory Proteins/chemistry ; Apoptosis Regulatory Proteins/genetics ; Apoptosis Regulatory Proteins/immunology ; Apoptosis Regulatory Proteins/metabolism ; COVID-19/drug therapy ; COVID-19/immunology ; Dose-Response Relationship, Immunologic ; Female ; Humans ; Immunoglobulin A/genetics ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Immunoglobulin M/adverse effects ; Immunoglobulin M/therapeutic use ; Mice ; Mice, Inbred BALB C ; Protein Engineering ; Receptors, Virus/antagonists & inhibitors ; Receptors, Virus/metabolism ; SARS-CoV-2/genetics
Czasopismo naukowe
Tytuł :
IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations.
Autorzy :
Ahmed AR; Department of Dermatology, The Center for Blistering Diseases, Tufts University School of Medicine, Boston, MA, United States.; Dermatology Service, Boston Veterans Administration Health Services, Boston, MA, United States.
Aksoy M; Department of Dermatology, The Center for Blistering Diseases, Tufts University School of Medicine, Boston, MA, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Sep 27; Vol. 12, pp. 727520. Date of Electronic Publication: 2021 Sep 27 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoimmune Diseases/*immunology
Immunoglobulin M/*immunology
Immunologic Deficiency Syndromes/*immunology
Skin Diseases, Vesiculobullous/*immunology
Adult ; Aged ; Aged, 80 and over ; Antigens, CD19/immunology ; Autoimmune Diseases/blood ; Autoimmune Diseases/drug therapy ; B-Lymphocytes/immunology ; Female ; Humans ; Immunoglobulin M/blood ; Immunoglobulin M/deficiency ; Immunoglobulins, Intravenous/therapeutic use ; Immunologic Deficiency Syndromes/blood ; Immunologic Deficiency Syndromes/drug therapy ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Rituximab/therapeutic use ; Skin Diseases, Vesiculobullous/blood ; Skin Diseases, Vesiculobullous/drug therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
Autorzy :
Ravindran R; Department of Pathology and Laboratory Medicine, University of California, Davis, CA, United States of America.
McReynolds C; Department of Entomology and Nematology, University of California, Davis, CA, United States of America.
Yang J; Department of Entomology and Nematology, University of California, Davis, CA, United States of America.
Hammock BD; Department of Entomology and Nematology, University of California, Davis, CA, United States of America.
Ikram A; National Institutes of Health, Rawalpindi, Pakistan.
Ali A; National Institutes of Health, Rawalpindi, Pakistan.
Bashir A; National Institutes of Health, Rawalpindi, Pakistan.
Zohra T; National Institutes of Health, Rawalpindi, Pakistan.
Chang WLW; California National Primate Research Center, University of California, Davis, CA, United States of America.; Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA, United States of America.
Hartigan-O'Connor DJ; California National Primate Research Center, University of California, Davis, CA, United States of America.
Rashidi HH; Department of Pathology and Laboratory Medicine, University of California, Davis, CA, United States of America.
Khan IH; Department of Pathology and Laboratory Medicine, University of California, Davis, CA, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Jul 09; Vol. 16 (7), pp. e0254367. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021).
Typ publikacji :
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Viral*/blood
Antibodies, Viral*/immunology
COVID-19*/blood
COVID-19*/immunology
Chemokines*/blood
Chemokines*/immunology
Coronavirus Nucleocapsid Proteins*/blood
Coronavirus Nucleocapsid Proteins*/immunology
Immunoglobulin G*/blood
Immunoglobulin G*/immunology
Immunoglobulin M*/blood
Immunoglobulin M*/immunology
SARS-CoV-2*/immunology
SARS-CoV-2*/metabolism
Spike Glycoprotein, Coronavirus*/blood
Spike Glycoprotein, Coronavirus*/immunology
Adult ; Animals ; Female ; Humans ; Macaca mulatta ; Male ; Middle Aged ; Phosphoproteins/blood ; Phosphoproteins/immunology ; Rabbits
Czasopismo naukowe
Tytuł :
Assessment of humoral responses in COVID-19 using various quantitative antibody tests.
Autorzy :
Wakui M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Kurafuji T; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Noguchi M; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Ohno A; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Yokota H; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Kikuchi H; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Murata M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
Annals of clinical biochemistry [Ann Clin Biochem] 2021 Jul; Vol. 58 (4), pp. 368-376. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Viral*/blood
Antibodies, Viral*/immunology
COVID-19*/blood
COVID-19*/diagnosis
COVID-19*/immunology
COVID-19 Nucleic Acid Testing*
COVID-19 Serological Testing*
Immunity, Humoral*
Immunoglobulin G*/blood
Immunoglobulin G*/immunology
Immunoglobulin M*/blood
Immunoglobulin M*/immunology
SARS-CoV-2*/immunology
SARS-CoV-2*/metabolism
Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
A high-throughput microsphere-based immunoassay of anti-SARS-CoV-2 IgM testing for COVID-19 diagnostics.
Autorzy :
Zhang D; DiaCarta Inc, Richmond, CA, United States of America.
Xu T; DiaCarta Inc, Richmond, CA, United States of America.
Chu E; DiaCarta Inc, Richmond, CA, United States of America.
Zhang A; DiaCarta Inc, Richmond, CA, United States of America.
Du J; DiaCarta Inc, Richmond, CA, United States of America.
Sha MY; DiaCarta Inc, Richmond, CA, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Sep 02; Vol. 16 (9), pp. e0248444. Date of Electronic Publication: 2021 Sep 02 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Microspheres*
Antibodies, Viral/*immunology
COVID-19 Serological Testing/*methods
Immunoassay/*methods
Immunoglobulin M/*immunology
SARS-CoV-2/*immunology
Antibodies, Viral/blood ; High-Throughput Screening Assays/methods ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Immunoglobulin M/blood ; ROC Curve ; SARS-CoV-2/physiology
Czasopismo naukowe
Tytuł :
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
Autorzy :
Oechtering J; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Schaedelin S; Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Benkert P; Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Müller S; Department of Neurology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Achtnichts L; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland.
Vehoff J; Department of Neurology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Disanto G; Neurocentre of Southern Switzerland, Multiple Sclerosis Centre, Ospedale Civico, Lugano, Switzerland.
Findling O; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland.
Fischer-Barnicol B; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Orleth A; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Chan A; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Pot C; Division of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
Barakovic M; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Rahmanzadeh R; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Galbusera R; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Heijnen I; Division of Medical Immunology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
Lalive PH; Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospital, Geneva, Switzerland.; Diagnostic Department, Division of Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland.; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Wuerfel J; Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University Basel, Basel, Switzerland.
Subramaniam S; Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Aeschbacher S; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
Conen D; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
Naegelin Y; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Maceski A; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Meier S; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Lincke T; Division of Neuroradiology, Department of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Lieb J; Division of Neuroradiology, Department of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Yaldizli Ö; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Sinnecker T; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University Basel, Basel, Switzerland.
Derfuss T; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Regeniter A; Medica Laboratory, Zürich, Switzerland.
Zecca C; Neurocentre of Southern Switzerland, Multiple Sclerosis Centre, Ospedale Civico, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
Gobbi C; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Neurocentre of Southern Switzerland, Multiple Sclerosis Centre, Ospedale Civico, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
Kappos L; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Granziera C; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Leppert D; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Kuhle J; Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Pokaż więcej
Corporate Authors :
Swiss Multiple Sclerosis Cohort Study
Źródło :
Annals of neurology [Ann Neurol] 2021 Sep; Vol. 90 (3), pp. 477-489. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Progression*
Severity of Illness Index*
Immunoglobulin M/*cerebrospinal fluid
Multiple Sclerosis/*cerebrospinal fluid
Multiple Sclerosis/*diagnostic imaging
Adult ; Biomarkers/blood ; Biomarkers/cerebrospinal fluid ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin M/biosynthesis ; Magnetic Resonance Imaging/trends ; Male ; Middle Aged ; Neurofilament Proteins/blood ; Neurofilament Proteins/cerebrospinal fluid ; Spinal Puncture/trends ; Young Adult
Czasopismo naukowe
Tytuł :
The relationship between anti-phosphatidylserine/prothrombin complex IgM antibodies and cutaneous ulcers in patients with cutaneous vasculitis.
Autorzy :
Kawakami T; Division of Dermatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Okiyama N; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kodera M; Department of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan.
Seishima M; Japan Community Health Care Organization Chukyo Hospital, Nagoya, Japan.
Yamaguchi Y; Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło :
The Journal of dermatology [J Dermatol] 2021 Sep; Vol. 48 (9), pp. 1457-1458. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Antiphospholipid*
Immunoglobulin M*
Phosphatidylserines*
Prothrombin*
Skin Ulcer*/immunology
Skin Ulcer*/pathology
Vasculitis*/immunology
Vasculitis*/pathology
Humans
Czasopismo naukowe
Tytuł :
Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae .
Autorzy :
Bettoni S; Department of Translational Medicine, Lund University, Malmö, Sweden.
Maziarz K; Department of Translational Medicine, Lund University, Malmö, Sweden.
Stone MRL; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Blaskovich MAT; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Potempa J; Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland.; Department of Oral Immunity and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY, United States.
Bazzo ML; Molecular Biology, Microbiology and Serology Laboratory, Federal University of Santa Catarina, Florianópolis, Brazil.
Unemo M; World Health Organization (WHO) Collaborating Centre for Gonorrhoea and other STIs, Department of Laboratory Medicine, Örebro University, Örebro, Sweden.
Ram S; Department of Medicine, Division of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA, United States.
Blom AM; Department of Translational Medicine, Lund University, Malmö, Sweden.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Sep 01; Vol. 12, pp. 726801. Date of Electronic Publication: 2021 Sep 01 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Complement Activation*
Anti-Bacterial Agents/*pharmacology
Complement C4b-Binding Protein/*administration & dosage
Drug Resistance, Bacterial/*drug effects
Immunoglobulin M/*administration & dosage
Neisseria gonorrhoeae/*drug effects
Azithromycin/pharmacology ; Ciprofloxacin/pharmacology ; Complement C4b-Binding Protein/genetics ; Humans ; Immunoglobulin M/genetics ; Neisseria gonorrhoeae/growth & development ; Recombinant Fusion Proteins/administration & dosage ; Spectinomycin/pharmacology
Czasopismo naukowe
Tytuł :
Critical role of IL-25-ILC2-IL-5 axis in the production of anti-Francisella LPS IgM by B1 B cells.
Autorzy :
Barbosa CHD; Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Lantier L; Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Reynolds J; Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Wang J; Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Re F; Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 Aug 27; Vol. 17 (8), pp. e1009905. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antibodies, Bacterial/*immunology
B-Lymphocyte Subsets/*immunology
Francisella tularensis/*immunology
Immunoglobulin M/*immunology
Interleukin-5/*metabolism
Interleukins/*metabolism
Lipopolysaccharides/*pharmacology
Animals ; Antibodies, Bacterial/metabolism ; B-Lymphocyte Subsets/metabolism ; Immunity, Innate ; Immunoglobulin M/metabolism ; Interleukin-5/genetics ; Interleukins/genetics ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Myeloid Differentiation Factor 88/physiology ; Receptors, Interleukin-17/physiology ; Toll-Like Receptor 2/physiology ; Tularemia/immunology ; Tularemia/microbiology ; Tularemia/pathology
Czasopismo naukowe
Tytuł :
Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies who recovered from SARS-COV-2 infection.
Autorzy :
Candoni A; Division of Hematology and SCT, University of Udine and ASUFC, Udine, Italy.
Pizzano U; Division of Hematology and SCT, University of Udine and ASUFC, Udine, Italy.
Fabris M; Department of Medicine and Clinical Pathology Institute, University of Udine and ASUFC, Udine, Italy.
Curcio F; Department of Medicine and Clinical Pathology Institute, University of Udine and ASUFC, Udine, Italy.
Fanin R; Division of Hematology and SCT, University of Udine and ASUFC, Udine, Italy.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2021 Aug; Vol. 39 (3), pp. 428-431. Date of Electronic Publication: 2021 May 05.
Typ publikacji :
Evaluation Study; Letter
MeSH Terms :
Antibodies, Viral/*blood
COVID-19/*blood
Hematologic Neoplasms/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
SARS-CoV-2/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antibodies, Viral/immunology ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; COVID-19/immunology ; Female ; Hematologic Neoplasms/drug therapy ; Hematologic Neoplasms/immunology ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Kinetics ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Seroconversion
Opinia redakcyjna
Tytuł :
Ultrasensitive, high-throughput, and rapid simultaneous detection of SARS-CoV-2 antigens and IgG/IgM antibodies within 10 min through an immunoassay biochip.
Autorzy :
Wang C; Institute of Marine Science and Technology, Shandong University, Qingdao, 266000, China.
Wang C; Institute of Marine Science and Technology, Shandong University, Qingdao, 266000, China.
Qiu J; Institute of Marine Science and Technology, Shandong University, Qingdao, 266000, China.
Gao J; Institute of Marine Science and Technology, Shandong University, Qingdao, 266000, China.
Liu H; Institute of Crystal Materials, Shandong University, Jinan, 250100, Shandong, China.
Zhang Y; Institute of Marine Science and Technology, Shandong University, Qingdao, 266000, China. .
Han L; Institute of Marine Science and Technology, Shandong University, Qingdao, 266000, China. .
Pokaż więcej
Źródło :
Mikrochimica acta [Mikrochim Acta] 2021 Jul 20; Vol. 188 (8), pp. 262. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoassay*
Antigens, Viral/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
SARS-CoV-2/*isolation & purification
Antigen-Antibody Reactions ; Antigens, Viral/immunology ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Nanoparticles/chemistry ; Particle Size ; SARS-CoV-2/immunology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Dynamics of the Magnitude, Breadth and Depth of the Antibody Response at Epitope Level Following Dengue Infection.
Autorzy :
Falconi-Agapito F; Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium.; Virology Unit, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Kerkhof K; Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium.
Merino X; Virology Unit, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Michiels J; Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium.
Van Esbroeck M; Department of Clinical Sciences, National Reference Center for Arboviruses, Institute of Tropical Medicine, Antwerp, Belgium.
Bartholomeeusen K; Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium.
Talledo M; Virology Unit, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Ariën KK; Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jul 05; Vol. 12, pp. 686691. Date of Electronic Publication: 2021 Jul 05 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Viral/*immunology
Dengue/*immunology
Dengue Virus/*immunology
Epitopes/*immunology
Immunoglobulin G/*immunology
Immunoglobulin M/*immunology
Adolescent ; Adult ; Antibodies, Viral/blood ; Belgium ; Cross Reactions/immunology ; Dengue/blood ; Dengue Virus/genetics ; Enzyme-Linked Immunosorbent Assay ; Epitopes/chemistry ; Female ; Flavivirus/immunology ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Middle Aged ; Peru ; Serologic Tests ; Travel ; Young Adult
Czasopismo naukowe
Tytuł :
The Role of IgM Antibodies in T Cell Lymphoma Protection in a Novel Model Resembling Anaplastic Large Cell Lymphoma.
Autorzy :
Jiang C; Somatic Hypermutation Group, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Zhao ML; Somatic Hypermutation Group, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Ramos L; San Diego Biomedical Research Institute, San Diego, CA.
Dobaczewska K; Microscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA.
Herbert R; Cellular and Molecular Pathology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Hobbie K; Integrated Laboratory Systems, Research Triangle Park, NC.
Mikulski Z; Microscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA.
Verkoczy L; San Diego Biomedical Research Institute, San Diego, CA .
Diaz M; Somatic Hypermutation Group, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC .; San Diego Biomedical Research Institute, San Diego, CA.
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 May 15; Vol. 206 (10), pp. 2468-2477. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Adoptive Transfer/*methods
Antibodies, Antinuclear/*administration & dosage
Cytidine Deaminase/*deficiency
Immunoglobulin M/*administration & dosage
Immunoglobulin M/*deficiency
Lymphoma, Large-Cell, Anaplastic/*immunology
Lymphoma, Large-Cell, Anaplastic/*therapy
Animals ; Autoimmunity/genetics ; B-Lymphocytes/immunology ; Cytidine Deaminase/genetics ; Disease Models, Animal ; Immunoglobulin M/genetics ; Lymphoma, Large-Cell, Anaplastic/genetics ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Inbred MRL lpr ; Mice, Knockout ; T-Lymphocytes/immunology ; Treatment Outcome ; Tumor Suppressor Protein p53/deficiency ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Tytuł :
Immunoglobulin M and Immunoglobulin G Subclass Distribution of Anti-galactose-Alpha-1,3-Galactose and Anti-N-Glycolylneuraminic Acid Antibodies in Healthy Korean Adults.
Autorzy :
Lee EJ; Department of Laboratory Medicine, Hallym University College of Medicine, Dongtan Sacred Heart Hospital, Hwaseong-si, Republic of Korea.
Lee H; Department of Laboratory Medicine, Hallym University College of Medicine, Hallym, University Sacred Heart Hospital, Anyang-si, Republic of Korea.
Park EM; Department of Laboratory Medicine, Hallym University College of Medicine, Hallym, University Sacred Heart Hospital, Anyang-si, Republic of Korea.
Kang HJ; Department of Laboratory Medicine, Hallym University College of Medicine, Hallym, University Sacred Heart Hospital, Anyang-si, Republic of Korea. Electronic address: .
Kim SJ; Department of Surgery, Myongji Hospital, Goyang-si, Republic of Korea.
Park CG; Xenotransplantation Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Microbiology and Immunology, Department of Biomedical Sciences, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2021 Jun; Vol. 53 (5), pp. 1762-1770. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Disaccharides/*immunology
Immunoglobulin G/*blood
Immunoglobulin M/*blood
Neuraminic Acids/*immunology
Adult ; Animals ; Endothelium, Vascular/cytology ; Endothelium, Vascular/immunology ; Endothelium, Vascular/metabolism ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoglobulin G/classification ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Male ; Middle Aged ; Swine
Czasopismo naukowe
Tytuł :
Progression of primary selective immunoglobulin M deficiency to common variable immunodeficiency.
Autorzy :
Narsai T; Division of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, Irvine, California.
Gupta S; Division of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, Irvine, California. Electronic address: .
Pokaż więcej
Źródło :
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2021 Jun; Vol. 126 (6), pp. 723-724. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Common Variable Immunodeficiency/*etiology
Dysgammaglobulinemia/*complications
Immunoglobulin M/*deficiency
Common Variable Immunodeficiency/blood ; Disease Progression ; Dysgammaglobulinemia/blood ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.
Autorzy :
Ebinger JE; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Fert-Bober J; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Advanced Clinical Biosystems Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Printsev I; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Wu M; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sun N; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Prostko JC; Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, USA.
Frias EC; Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, USA.
Stewart JL; Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, USA.
Van Eyk JE; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Advanced Clinical Biosystems Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Braun JG; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. .; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. .
Cheng S; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. .
Sobhani K; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jun; Vol. 27 (6), pp. 981-984. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Viral/*biosynthesis
Antigens, Viral/*immunology
COVID-19/*immunology
COVID-19 Vaccines/*immunology
Coronavirus Nucleocapsid Proteins/*immunology
Immunoglobulin G/*biosynthesis
Immunoglobulin M/*biosynthesis
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Angiotensin-Converting Enzyme 2/metabolism ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Antibody Specificity ; COVID-19 Vaccines/adverse effects ; Convalescence ; Female ; Health Personnel ; Humans ; Immunization, Secondary/adverse effects ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Immunologic Memory ; Male ; Middle Aged ; Phosphoproteins/immunology ; Symptom Assessment ; Vaccination
Czasopismo naukowe
Tytuł :
Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?
Autorzy :
Krygier R; NZOZ Gemini, Żychlin, Poland (Infectious Diseases Outpatient Clinic).
Stępień PM; Jan Kochanowski University, Kielce, Poland (Department of Infectious Diseases).
Zarębska-Michaluk D; Jan Kochanowski University, Kielce, Poland (Department of Infectious Diseases).
Pokaż więcej
Źródło :
International journal of occupational medicine and environmental health [Int J Occup Med Environ Health] 2021 May 27; Vol. 34 (2), pp. 203-209. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Pandemics*
Antibodies, Viral/*analysis
COVID-19/*epidemiology
Immunoglobulin G/*analysis
Immunoglobulin M/*analysis
SARS-CoV-2/*immunology
Adult ; COVID-19/immunology ; COVID-19/virology ; Female ; Humans ; Immunoglobulin M/immunology ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
High-Throughput Detection of Autoantigen-Specific B Cells Among Distinct Functional Subsets in Autoimmune Donors.
Autorzy :
Joosse BA; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
Jackson JH; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Biomedical Sciences, School of Medicine Greenville, University of South Carolina, Greenville, SC, United States.
Cisneros A; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
Santhin AB; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
Smith SA; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4), Nashville, TN, United States.
Moore DJ; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4), Nashville, TN, United States.; Department of Pediatrics, Division of Endocrinology & Diabetes, Vanderbilt University Medical Center, Nashville, TN, United States.
Crofford LJ; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4), Nashville, TN, United States.
Wilfong EM; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Medicine, Allergy, Pulmonary, and Critical Care, Vanderbilt University Medical Center, Nashville, TN, United States.
Bonami RH; Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4), Nashville, TN, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 May 24; Vol. 12, pp. 685718. Date of Electronic Publication: 2021 May 24 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoimmune Diseases/*immunology
B-Lymphocyte Subsets/*physiology
B-Lymphocytes/*immunology
Immunoglobulin D/*metabolism
Immunoglobulin M/*metabolism
Adult ; Aged ; Autoantibodies/immunology ; Autoantigens/immunology ; Female ; Humans ; Immunoglobulin D/genetics ; Immunoglobulin M/genetics ; Leukocytes, Mononuclear/immunology ; Male ; Middle Aged ; Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies